Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7243 results

Sort By:

Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope

Study ID: NCT05429203
Start Date: 2022-10-25
End Date: 2024-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment

Duodenoscope with single-use distal cover

Conventional duodenoscope

Sponsor

Stanford University

Source: clinicaltrials.gov

Share:
Add to list

Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study

Study ID: NCT05019703
Start Date: 2023-04-25
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Atezolizumab

Cabozantinib

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Venetoclax to Augment Epigenetic Modification and Chemotherapy

Study ID: NCT05317403
Start Date: 2023-03-31
End Date: 2027-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

Venetoclax

Azacitidine

Vorinostat

Cytarabine

Fludarabine

Filgrastim

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)

Study ID: NCT04991103
Start Date: 2021-09-22
End Date: 2028-08-27
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Darward

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners

Study ID: NCT02596490
Start Date: 2016-04-06
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Questionnaires

Meditation and Discussion Sessions

Cancer-Related Discussion Program

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer

Study ID: NCT06397703
Start Date: 2024-04-16
End Date: 2031-04-16
Study Type

Interventional

Study Phase

Phase2

No. of Participants

392

Intervention / Treatment

Leuprolide, Degarelix or Relugolix

Stereotactic body radiation therapy/radiosurgery (SBRT)

Sponsor

NYU Langone Health

Source: clinicaltrials.gov

Share:
Add to list

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Study ID: NCT06815003
Start Date: 2025-04-18
End Date: 2028-10-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Allogeneic Hematopoietic Stem Cell Transplantation

Biospecimen Collection

Bone Marrow Biopsy

Computed Tomography

Cyclophosphamide

Echocardiography

Fludarabine

Melphalan

Multigated Acquisition Scan

Administration questionnaire

Tacrolimus

Vedolizumab

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia

Study ID: NCT02877303
Start Date: 2016-11-01
End Date: 2026-11-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Blinatumomab

Cyclophosphamide

Cytarabine

Dexamethasone

Doxorubicin Hydrochloride

Inotuzumab Ozogamicin

Laboratory Biomarker Analysis

Mercaptopurine

Methotrexate

Ofatumumab

Prednisone

Rituximab

Vincristine Sulfate

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors

Study ID: NCT06132503
Start Date: 2023-01-03
End Date: 2028-11-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

110

Intervention / Treatment

LP-284

Sponsor

Lantern Pharma Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia

Study ID: NCT06401603
Start Date: 2024-08-06
End Date: 2029-01-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Decitabine

Art capacity

Fluffy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list